TY - JOUR
T1 - Natural killer cells regulate T cell immune responses in primary biliary cirrhosis
AU - Shimoda, Shinji
AU - Hisamoto, Satomi
AU - Harada, Kenichi
AU - Iwasaka, Sho
AU - Chong, Yong
AU - Nakamura, Minoru
AU - Bekki, Yuki
AU - Yoshizumi, Tomoharu
AU - Shirabe, Ken
AU - Ikegami, Toru
AU - Maehara, Yoshihiko
AU - He, Xiao Song
AU - Gershwin, M. Eric
AU - Akashi, Koichi
N1 - Funding Information:
Financial support was provided by Grand-in-Aid for Scientific Research of Japan (26461012) and the National Institutes of Health (grant no.: DK39588).
Publisher Copyright:
© 2015 by the American Association for the Study of Liver Diseases.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - The hallmark of primary biliary cirrhosis (PBC) is the presence of autoreactive T- and B-cell responses that target biliary epithelial cells (BECs). Biliary cell cytotoxicity is dependent upon initiation of innate immune responses followed by chronic adaptive, as well as bystander, mechanisms. Critical to these mechanisms are interactions between natural killer (NK) cells and BECs. We have taken advantage of the ability to isolate relatively pure viable preparations of liver-derived NK cells, BECs, and endothelial cells, and studied interactions between NK cells and BECs and focused on the mechanisms that activate autoreactive T cells, their dependence on interferon (IFN)-γ, and expression of BEC major histocompatibility complex (MHC) class I and II molecules. Here we show that at a high NK/BEC ratio, NK cells are cytotoxic for autologous BECs, but are not dependent on autoantigen, yet still activate autoreactive CD4+ T cells in the presence of antigen presenting cells. In contrast, at a low NK/BEC ratio, BECs are not lysed, but IFN-γ production is induced, which facilitates expression of MHC class I and II molecules on BEC and protects them from lysis upon subsequent exposure to autoreactive NK cells. Furthermore, IFN-γ secreted from NK cells after exposure to autologous BECs is essential for this protective function and enables autoreactive CD4+ T cells to become cytopathic. Conclusions: NK cell-mediated innate immune responses are likely critical at the initial stage of PBC, but also facilitate and maintain the chronic cytopathic effect of autoantigen-specific T cells, essential for progression of disease.
AB - The hallmark of primary biliary cirrhosis (PBC) is the presence of autoreactive T- and B-cell responses that target biliary epithelial cells (BECs). Biliary cell cytotoxicity is dependent upon initiation of innate immune responses followed by chronic adaptive, as well as bystander, mechanisms. Critical to these mechanisms are interactions between natural killer (NK) cells and BECs. We have taken advantage of the ability to isolate relatively pure viable preparations of liver-derived NK cells, BECs, and endothelial cells, and studied interactions between NK cells and BECs and focused on the mechanisms that activate autoreactive T cells, their dependence on interferon (IFN)-γ, and expression of BEC major histocompatibility complex (MHC) class I and II molecules. Here we show that at a high NK/BEC ratio, NK cells are cytotoxic for autologous BECs, but are not dependent on autoantigen, yet still activate autoreactive CD4+ T cells in the presence of antigen presenting cells. In contrast, at a low NK/BEC ratio, BECs are not lysed, but IFN-γ production is induced, which facilitates expression of MHC class I and II molecules on BEC and protects them from lysis upon subsequent exposure to autoreactive NK cells. Furthermore, IFN-γ secreted from NK cells after exposure to autologous BECs is essential for this protective function and enables autoreactive CD4+ T cells to become cytopathic. Conclusions: NK cell-mediated innate immune responses are likely critical at the initial stage of PBC, but also facilitate and maintain the chronic cytopathic effect of autoantigen-specific T cells, essential for progression of disease.
UR - http://www.scopus.com/inward/record.url?scp=84955181044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955181044&partnerID=8YFLogxK
U2 - 10.1002/hep.28122
DO - 10.1002/hep.28122
M3 - Article
C2 - 26264889
AN - SCOPUS:84955181044
SN - 0270-9139
VL - 62
SP - 1817
EP - 1827
JO - Hepatology
JF - Hepatology
IS - 6
ER -